Accessibility Menu
Adicet Bio Stock Quote

Adicet Bio (NASDAQ: ACET)

$0.92
(-6.8%)
-0.07
Price as of October 21, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$0.92
Daily Change
(-6.8%) $0.07
Day's Range
$0.9 - $1.03
Previous Close
$0.92
Open
$0.99
Beta
1.21
Volume
2,271,468
Average Volume
1,226,985
Market Cap
141.3M
Market Cap / Employee
$0.92M
52wk Range
$0.45 - $1.52
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
-$1.3
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Adicet Bio Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
ACET-38.13%-92.83%-40.97%-94%
S&P+14.84%+96.04%+14.41%+99%

Adicet Bio Company Info

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$0.00M0.0%
Gross Profit-$1.60M0.1%
Market Cap$50.45M-49.3%
Market Cap / Employee$0.33M0.0%
Employees1526.3%
Net Income-$31.22M-4.4%
EBITDA-$30.79M1.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$34.72M-84.5%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$12.41M-21.0%
Short Term Debt$2.95M-13.7%

Ratios

Q2 2025YOY Change
Return On Assets-54.95%-4.7%
Return On Invested Capital-40.82%-1.2%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$26.68M-12.5%
Operating Free Cash Flow-$26.63M-13.7%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book0.500.370.330.31-18.66%
Price to Tangible Book Value0.500.370.330.31-18.66%
Enterprise Value to EBITDA1.682.462.321.76-42.44%
Return on Equity-58.0%-65.7%-55.8%-64.4%11.20%
Total Debt$18.20M$17.23M$16.25M$15.36M-19.73%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.